Two NK-3 receptor subtypes: demonstration by biological and binding assays

Area of Science:

• Pharmacology
• Neuroscience
• Receptor Biology

Background:

• Previous binding assays suggested the existence of two neurokinin NK-3 receptor subtypes.
• The precise pharmacological characterization and distinction of these subtypes remained unclear.
• Understanding NK-3 receptor subtypes is crucial for developing targeted therapeutics.

Purpose of the Study:

• To confirm the existence of two distinct neurokinin NK-3 receptor subtypes.
• To pharmacologically differentiate these subtypes using selective antagonists and agonists.
• To propose distinct nomenclature for the identified receptor subtypes.

Main Methods:

• Experiments were conducted on rat portal vein and guinea-pig ileum preparations.
• Selective NK-1 and NK-2 antagonists (CP 96345 and SR 48968) were employed.
• Agonist potency and antagonist affinity (pA2, IC50) were measured in both biological and binding assays.

Main Results:

• Distinct agonist potency orders were observed for neurokinins and tachykinins on rat portal vein versus guinea-pig ileum.
• The NK-3 selective agonist [MePhe7]NKB showed differential activity ([MePhe7]NKB >> senktide on rat portal vein; [MePhe7]NKB = senktide on guinea-pig ileum).
• Antagonists SR 48968 and R-486 exhibited significantly different affinities and activities across the two tissues, confirming pharmacological divergence.

Conclusions:

• The study provides definitive confirmation of two pharmacologically distinct neurokinin NK-3 receptor subtypes.
• The receptor found in the guinea-pig ileum is proposed to be named NK-3A.
• The receptor identified in the rat portal vein is proposed to be named NK-3B.